Lineage Cell Therapeutics (LCTX) News Today $1.30 -0.02 (-1.52%) Closing price 05/22/2026 04:10 PM EasternExtended Trading$1.30 -0.01 (-0.38%) As of 05/22/2026 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock LCTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Lineage Cell Therapeutics Q1 Earnings Call HighlightsMay 15, 2026 | marketbeat.comLineage Cell Therapeutics (LCTX) price target increased by 14.58% to 5.61May 14, 2026 | msn.comLineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highlights: Strategic Advances and ...May 13, 2026 | finance.yahoo.comLineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2026 Earnings Call TranscriptMay 13, 2026 | insidermonkey.comLineage Cell Therapeutics, Inc. (LCTX) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comLineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 12, 2026 | businesswire.comLineage Cell Therapeutics (LCTX) Projected to Post Quarterly Earnings on TuesdayMay 5, 2026 | marketbeat.comLineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026May 5, 2026 | businesswire.comD. Boral Capital Reaffirms Buy Rating for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)May 4, 2026 | marketbeat.comCanaccord Genuity initiates coverage of Lineage Cell Therapeutics (LCTX) with buy recommendationApril 29, 2026 | msn.comLineage Cell Therapeutics (NYSEAMERICAN:LCTX) Earns Buy Rating from Analysts at Canaccord Genuity GroupApril 28, 2026 | marketbeat.comLineage Cell (LCTX) launches its latest cell therapy programMarch 31, 2026 | msn.comLineage Launches New Cell Therapy Program in Corneal Endothelial DiseaseMarch 24, 2026 | finance.yahoo.comLineage Cell Therapeutics (NYSEAMERICAN:LCTX) CEO Purchases $24,300.00 in StockMarch 13, 2026 | insidertrades.comLineage Cell Therapeutics Extends Runway Amid R&D SurgeMarch 7, 2026 | tipranks.comLineage extends cash runway into Q2 2028 while advancing OpRegen and new pipeline programsMarch 5, 2026 | seekingalpha.comLineage Cell Therapeutics, Inc. (LCTX) Q4 2025 Earnings Call TranscriptMarch 5, 2026 | seekingalpha.comLineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateMarch 5, 2026 | finance.yahoo.comLineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026February 26, 2026 | finance.yahoo.comLineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026February 26, 2026 | businesswire.comLineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor BioscienceJanuary 6, 2026 | businesswire.comD. Boral Capital Maintains Lineage Cell Therapeutics (LCTX) Buy RecommendationNovember 25, 2025 | msn.comHC Wainwright & Co. Maintains Lineage Cell Therapeutics (LCTX) Buy RecommendationNovember 25, 2025 | msn.comLineage Cell’s OpRegen shows evidence of progress, says H.C. WainwrightNovember 24, 2025 | msn.comLineage Cell says first OpRegen development milestone under Roche pact achievedNovember 24, 2025 | msn.comLineage Therap Sells 12 Million Shares to JanusNovember 12, 2025 | tipranks.comLineage Cell Therapeutics: Progress Amid Financial ChallengesNovember 8, 2025 | msn.comLineage Cell Therapeutics Inc (LCTX) Q3 2025 Earnings Call Highlights: Strategic Partnerships ...November 7, 2025 | finance.yahoo.comLineage Cell Therapeutics Reports Q3 2025 ResultsNovember 6, 2025 | tipranks.comLineage Cell Therapeutics, Inc. (LCTX) Q3 2025 Earnings Call TranscriptNovember 6, 2025 | seekingalpha.comLineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business UpdateNovember 6, 2025 | businesswire.comLineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025October 30, 2025 | finance.yahoo.comLineage Cell Therapeutics Advances in Spinal Cord Injury Treatment with DOSED StudyOctober 27, 2025 | tipranks.comHC Wainwright Affirms Buy Rating on Lineage Cell Therapeutics Inc. (LCTX) amid Type 1 Diabetes PushSeptember 29, 2025 | msn.comLineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen TrialSeptember 25, 2025 | finance.yahoo.comLineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen TrialSeptember 23, 2025 | insidermonkey.comLineage Cell Therapeutics, Inc. (LCTX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Prepared Remarks TranscriptSeptember 13, 2025 | seekingalpha.comLineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 DiabetesSeptember 8, 2025 | finance.yahoo.comLineage Cell Therapeutics to Present at September 2025 Investor ConferencesSeptember 2, 2025 | businesswire.com5 Analysts Assess Lineage Cell Therapeutics: What You Need To KnowAugust 28, 2025 | benzinga.comLineage Cell Therapeutics reports Q2 EPS (13c), consensus (3c)August 12, 2025 | msn.comLineage Cell Therapeutics, Inc. (LCTX) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comLineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord InjuryAugust 5, 2025 | finance.yahoo.comLineage Cell Therapeutics Inc. Stock Grades | LCTX | Barron'sJuly 18, 2025 | barrons.comLineage Cell Therapeutics Inc. - LCTX | Barron'sJuly 18, 2025 | barrons.comLineage Cell Therapeutics shareholders approve board slate and equity plan amendment - Investing.comJuly 4, 2025 | investing.comLCTX Lineage Cell Therapeutics, Inc. - Seeking AlphaJune 27, 2025 | seekingalpha.comLineage Cell Therapeutics (AMEX:LCTX) Stock, Short Interest ReportJune 23, 2025 | benzinga.comLineage Cell Therapeutics (AMEX:LCTX) Stock, Insider Trading ActivityJune 23, 2025 | benzinga.comLineage Cell Therapeutics Earnings Estimates, EPS & Revenue | AMEX:LCTX | BenzingaJune 23, 2025 | benzinga.com Get Lineage Cell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LCTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LCTX Media Mentions By Week LCTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LCTX News Sentiment▼0.000.45▲Average Medical News Sentiment LCTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LCTX Articles This Week▼01▲LCTX Articles Average Week Get the Latest News and Ratings for LCTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Olema Pharmaceuticals News Maplight Therapeutics News Maze Therapeutics News Compass Pathways News Jade Biosciences News Maravai LifeSciences News Collegium Pharmaceutical News DBV Technologies News Evotec News Alvotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:LCTX) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGold surged 600 dollars last time this indicator peakedThe Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...Porter & Company | SponsoredJune 12: Elon Musk’s “Day-One Retirement Plan.”SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredJune 4: The day smart money moves (not June 12)Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
